Skip to main content

Zynex, Inc. (ZYXI)

NASDAQ: ZYXI · IEX Real-Time Price · USD
12.40
-0.03 (-0.24%)
After-hours:Oct 25, 2021 7:14 PM EDT
12.43
0.11 (0.89%)
At close: Oct 25, 4:00 PM
Market Cap432.07M
Revenue (ttm)100.78M
Net Income (ttm)5.22M
Shares Out34.81M
EPS (ttm)0.15
PE Ratio82.87
Forward PE19.16
Dividendn/a
Ex-Dividend Daten/a
Volume79,716
Open12.34
Previous Close12.32
Day's Range12.16 - 12.49
52-Week Range10.66 - 22.89
Beta0.98
AnalystsStrong Buy
Price Target23.40 (+88.3%)
Est. Earnings DateOct 26, 2021

About ZYXI

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary inco...

IndustryHealth Care Equipment & Supplies
Founded1996
Employees768
Stock ExchangeNASDAQ
Ticker SymbolZYXI
Full Company Profile

Financial Performance

In 2020, Zynex's revenue was $80.12 million, an increase of 76.20% compared to the previous year's $45.47 million. Earnings were $9.07 million, a decrease of -4.40%.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Zynex stock is "Strong Buy." The 12-month stock price forecast is 23.40, which is an increase of 88.25% from the latest price.

Price Target
$23.40
(88.25% upside)
Analyst Consensus: Strong Buy

News

Zynex Schedules 2021 Third Quarter Earnings Call

ENGLEWOOD, Colo., Oct. 25, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

16 hours ago - PRNewsWire

Wall Street Analysts Believe Zynex Inc. (ZYXI) Could Rally 87%: Here's is How to Trade

The mean of analysts' price targets for Zynex Inc. (ZYXI) points to an 86.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys...

5 days ago - Zacks Investment Research

Zynex Announces 70% Order Growth and Increases Q3 2021 Adjusted EBITDA Estimate

ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain manag...

1 week ago - PRNewsWire

Zynex to Display its CM-1500 Fluid Monitoring System at the American Society of Anesthesiologists Annual Conference

ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

2 weeks ago - PRNewsWire

Zynex Inc. (ZYXI) Surpasses Q2 Earnings Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 14.29% and -0.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Zynex: Q2 Earnings Insights

Shares of Zynex (NASDAQ:ZYXI) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 11.11% year over year to $0.08, which beat the estim...

2 months ago - Benzinga

Zynex Announces 2021 Second Quarter Earnings

ENGLEWOOD, Colo., July 29, 2021 /PRNewswire/ -- 2021 Second Quarter Revenue increased 61% year over year to $31.0 million Orders increased 247% Net income of $2.8 million; Diluted EPS $0.08 Adjusted EBI...

2 months ago - PRNewsWire

Zynex Schedules 2021 Second Quarter Earnings Call

ENGLEWOOD, Colo., July 21, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

3 months ago - PRNewsWire

Zynex Inc. (ZYXI) Stock Jumps 6.5%: Will It Continue to Soar?

Zynex Inc. (ZYXI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

3 months ago - Zacks Investment Research

Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate

ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain manag...

3 months ago - PRNewsWire

Zynex Announces Uplisting to the Nasdaq Global Select Market®

ENGLEWOOD, Colo., July 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

3 months ago - PRNewsWire

Zynex to Present at the Ladenburg Thalmann Virtual Annual Healthcare Conference

ENGLEWOOD, Colo., July 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain mana...

3 months ago - PRNewsWire

Zynex Inc. (ZYXI) Reports Q1 Loss, Tops Revenue Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 0.00% and 2.10%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Zynex Announces 2021 First Quarter Earnings

ENGLEWOOD, Colo., April 29, 2021 /PRNewswire/ -- 2021 First Quarter Revenue increased 58% year over year to $24.1 million Orders increased 140% Net loss of $0.7 million; GAAP loss per share $0.02 Adjust...

5 months ago - PRNewsWire

Zynex Appoints Donald Gregg as Vice President of Sales and Operations of Monitoring Solutions Division

ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

6 months ago - PRNewsWire

Zynex Schedules 2021 First Quarter Earnings Call

ENGLEWOOD, Colo., April 19, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

6 months ago - PRNewsWire

Zynex Announces 140% Year over Year Order Growth in Q1-2021

ENGLEWOOD, Colo., April 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain mana...

6 months ago - PRNewsWire

Zynex Growth Leads to New Corporate Headquarters

ENGLEWOOD, Colo., April 9, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

6 months ago - PRNewsWire

Zynex Recognized as the Sixth Largest Biotechnology/Bioscience Company in Colorado

ENGLEWOOD, Colo., March 30, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ma...

6 months ago - PRNewsWire

Airbnb, Centerpoint, Editas and More Friday Afternoon Analyst Calls

With the trading day more than halfway over, the broad markets recovered slightly from Thursday's downturn, with the exception of the Dow Jones industrial average.

7 months ago - 24/7 Wall Street

Why Zynex Stock Is Crashing Today

Investors are reacting negatively to the company's Q4 results and Q1 outlook.

7 months ago - The Motley Fool

Recap: Zynex Q4 Earnings

Shares of Zynex (NASDAQ:ZYXI) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 44.44% over the past year to $0.05, which missed the esti...

8 months ago - Benzinga

Zynex Announces 2020 Fourth Quarter and Full Year Earnings

ENGLEWOOD, Colo., Feb. 25, 2021 /PRNewswire/ -- 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net income of $9.1 million; Diluted EPS $0.26 Adjusted EBITDA $1...

8 months ago - PRNewsWire

Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call

ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

8 months ago - PRNewsWire

Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical

ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain man...

8 months ago - PRNewsWire